PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11956159-4	2002	Using inhibitors of serine/threonine phosphatase activity (okadaic acid) and phosphotyrosine phosphatase activity (peroxyvanadate), we can inhibit the cAMP-inducible binding of the steroidogenic factor-1 (SF-1), p54(nrb)/NonO, and polypyrimidine tract-binding protein-associated splicing factor (PSF) complex required for regulation of transcription to the promoter of hCYP17.	Okadaic Acid	59-71	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	369-375	
11956159-5	2002	Further, both okadaic acid and peroxyvanadate attenuate cAMP-stimulated increases in endogenous hCYP17 mRNA expression and in hCYP17 promoter-reporter construct luciferase activity.	Okadaic Acid	14-26	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	96-102	
11956159-5	2002	Further, both okadaic acid and peroxyvanadate attenuate cAMP-stimulated increases in endogenous hCYP17 mRNA expression and in hCYP17 promoter-reporter construct luciferase activity.	Okadaic Acid	14-26	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	126-132